Posted by SalArmy4me on May 25, 2001, at 13:32:40
In reply to Wellbutrin and Ecstasy, posted by Thomas Allen Brown on May 24, 2001, at 14:14:55
Ecstasy use with Wellbutrin is safe--if you disregard the mountain full of scientific evidence that proves that Ecstasy causes depression:
1: Bailly D. Related Articles
[Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
Encephale. 1999 Nov-Dec;25(6):595-602.2: Henry JA.
Ecstasy and serotonin depletion.
Lancet. 1996 Mar 23;347(9004):833.3: Pennings EJ, Konijn KZ, de Wolff FA. [Clinical and toxicologic aspects of the use of Ecstasy].
Ned Tijdschr Geneeskd. 1998 Aug 29;142(35):1942-6. Review. Dutch.4: Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delsignore R. Related Articles
Serotonergic function altered after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans.
Int Clin Psychopharmacol. 1998 Jan;13(1):1-9.5: Liberg JP, Hovda KE, Nordby G, Jacobsen D. Related Articles
[Ecstasy--long-lasting effects]?
Tidsskr Nor Laegeforen. 1998 Nov 20;118(28):4384-
7. Norwegian.6: Schifano F, Di Furia L, Forza G, Minicuci N, Bricolo R. Related Articles
MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
Drug Alcohol Depend. 1998 Sep 1;52(1):85-90.7: Parrott AC, Lasky J. Related Articles
Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
Psychopharmacology (Berl). 1998 Oct;139(3):261-8.8: Zhou FC, Tao-Cheng JH, Segu L, Patel T, Wang Y. Related Articles
Serotonin transporters affected by MDMA are located on the axons beyond the synaptic junctions: anatomical and functional evidence.
Brain Res. 1998 Sep 14;805(1-2):241-54.9: Curran HV, Travill RA. Related Articles
Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy').
Addiction. 1997 Jul;92(7):821-31.10: Yau JL, Noble J, Seckl JR. Related Articles
Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-MDMA: role of corticosterone and serotonin.
Neuroscience. 1997 May;78(1):111-21.11: Miller RT, Lau SS, Monks TJ.
2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine (MDMA), decreases brain serotonin concentrations.
Eur J Pharmacol. 1997 Apr 4;323(2-3):173-80.12: White SR, Obradovic T, Imel KM, Wheaton MJ. Related Articles
The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.
Prog Neurobiol. 1996 Aug;49(5):455-79. Review.13: Immunomodulating activity of MDMA
Ann N Y Acad Sci. 2000;914:215-24.14: Pacifici R, Zuccaro P, Shannon, M.
Methylenedioxymethamphetamine (MDMA, "Ecstasy").
Pediatr Emerg Care. 2000 Oct;16(5):377-80.15: Nielsen JC, Nicholson K, Pitzner-Jorgensen BL, Unden M. Related Articles
[Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
Ugeskr Laeger. 1995 Feb 6;157(6):724-7. Review. Danish.16: McGuire PK, Cope H, Fahy TA.
Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')
Br J Psychiatry. 1994 Sep;165(3):391-5.17: Riedlinger TJ, Riedlinger JE.
Psychedelic and entactogenic drugs in the exacerbation of depression.
J Psychoactive Drugs. 1994 Jan-Mar;26(1):41-55. Review.18: Peroutka SJ, Newman H, Harris H.
Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology. 1988 Dec;1(4):273-19: Schmidt CJ, Taylor VL. Related Articles
Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine (MDMA).
Biochem Pharmacol. 1987 Dec 1;36(23):4095-102.20: Steele TD, Nichols DE, Yim GK. Related Articles
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Biochem Pharmacol. 1987 Jul 15;36(14):2297-303.21: Frith CH, Chang LW, Lattin DL, Walls RC, Hamm J, Doblin R.
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat.
Fundam Appl Toxicol. 1987 Jul;9(1):110-9.22: Gibb JW, Stone DM, Stahl DC, Hanson GR.
The effects of amphetamine-like designer drugs on monoaminergic systems in the brain.
NIDA Res Monogr. 1987;76:316-21.23: Stone DM, Stahl DC, Hanson GR, Gibb JW.
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
Eur J Pharmacol. 1986 Aug 22;128(1-2):41-8.24: Schifano, F.
Human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies.
Neuropsychobiology. 2000;42(1):25-33. Review.--The Salvation Army Adult Rehabilitation Center Command: Changing the World One Life at a Time
poster:SalArmy4me
thread:64139
URL: http://www.dr-bob.org/babble/20010522/msgs/64229.html